Monarch Precision Oncology · 2026 evidence map

Gastrointestinal Cancer Precision Oncology Map

Precision pathways for gastric and gastroesophageal-junction adenocarcinoma, esophageal adenocarcinoma and squamous cancer, and gastrointestinal stromal tumor.

Gastric / GEJEsophageal / ESCCHER2PD-L1CLDN18.2MSI / MMRKIT / PDGFRAGIST
Clinical discussion support only. Confirm histology, anatomic site, stage, resectability, HER2, PD-L1, CLDN18.2, MMR/MSI, EBV when relevant, nutrition, organ function, neuropathy, cardiopulmonary risk, KIT/PDGFRA genotype for GIST, current prescribing information, local guidelines and regulatory access.
Gastrointestinal research mechanism